Covered recipient · General Payments record
DELA AMOUSSOU
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$550.25
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $271.21 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $72.26 | 4 |
| UCB, Inc. | $60.59 | 2 |
| ARGENX US, INC. | $29.05 | 1 |
| Biogen, Inc. | $28.45 | 1 |
| Neurelis, Inc. | $23.30 | 1 |
| Amgen Inc. | $21.49 | 1 |
| Teva Pharmaceuticals USA, Inc. | $19.15 | 1 |
| LivaNova USA, Inc. | $16.92 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.56 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103220659 | CMS |
| ABBVIE INC. | $14.36 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103220661 | CMS |
| ABBVIE INC. | $21.24 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103220663 | CMS |
| ABBVIE INC. | $15.10 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103220665 | CMS |
| Amgen Inc. | $21.49 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111516757 | CMS |
| ARGENX US, INC. | $29.05 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142123235 | CMS |
| Biogen, Inc. | $28.45 | 02/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104840787 | CMS |
| LivaNova USA, Inc. | $16.92 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152786491 | CMS |
| Neurelis, Inc. | $23.30 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145631354 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.15 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151515653 | CMS |
| UCB, Inc. | $21.62 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393317 | CMS |
| UCB, Inc. | $38.97 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143393322 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.